Akiko Shimamura, MD, PhD
Director, Bone Marrow Failure and Myelodysplastic Syndrome Programs, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Associate Professor of Pediatrics, Harvard Medical School
Bone marrow failure, Aplastic anemia, Myelodysplastic syndromes (MDS), Cancer predisposition
Boston Children's Hospital
300 Longwood Ave.
Boston, MA 02115
Pediatric Hematology/Oncology, 1997
Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 1997
Johns Hopkins Hospital, Pediatrics, 1994
University of Rochester School of Medicine, 1991
Children with rare disorders, such as bone marrow failure and MDS, deserve the same level of medical care and the same chance to live a healthy life as children with more common disorders. We are striving to identify the causes of bone marrow failure and MDS to develop better treatments for these disorders. We partner with the patient, the family, and the referring physicians to work together as a team to develop and implement an individualized medical plan. My research spans basic scientific studies and clinical studies with the goal of improving the diagnosis and treatment of patients with bone marrow failure and MDS. Our patients benefit from access to the exciting scientific and clinical advances and cutting edge technologies developed by researchers at Harvard.
Video: Meet Akiko Shimamura
Akiko Shimamura, MD, PhD, discusses our personalized approach to treatment and care for children with bone marrow failure and myelodysplastic syndromes (MDS) at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.